Biotech · Private company · Monrovia, CA, US
Invizyne Technologies, Inc.
Track this companyFree. Adds Invizyne Technologies, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- SimplePath IIB: Pre-clinical development of Cannabinoid analogsFiscal year 2026 · $1MNIH RePORTER 2R44GM159516-05A1 · fetched Nov 12, 2026
- Bio-Click: A cell-free high-throughput platform for the engineering of enzymatic group transfer reactionsFiscal year 2025 · $283.8KNIH RePORTER 1R43GM157956-01 · fetched Nov 12, 2026
- GlyCoSAM: Glycolysis coupled S-adenosyl methionine regeneration for cell-free methylation reactionsFiscal year 2024 · $243.5KNIH RePORTER 1R43GM153108-01 · fetched Nov 12, 2026